EN IT

Reserved

British American Tobacco: bullish confirmation challenges the sell signal

·45 min read
EXECUTIVE VIEW

British American Tobacco week 3 sell signal — technical analysis shows a bullish confirmation week, a clear warning for this trade setup. The stock ranks last among 57 EU-UK sell signals; performance is −7.88% with trading not recommended per our model.

Reserved analysis Subscribe to read →
Reserved

BASF: selling pressure picks up, but double bottom demands attention

·45 min read
EXECUTIVE VIEW

BASF stock technical analysis — week 4 of a sell signal: the week closed down 2.5% with seller-dominated volume. Three observation weeks closed sideways; sell signal not yet confirmed by the market. Trading not recommended per our model.

Reserved analysis Subscribe to read →
Reserved

Barclays up 15.8% since entry: trailing stop locks in the gain

·46 min read
EXECUTIVE VIEW

Barclays weekly trade setup at week 11 — all 3 model time windows passed, +15.8% performance since entry, trailing stop on the Inversion Point now locks in a solid portion of the accumulated gain.

Reserved analysis Subscribe to read →
Reserved

BAE Systems: decline holds, but daily double bottom clouds the picture

·45 min read
EXECUTIVE VIEW

BAE Systems at week 13 of a sell signal. The week closed -2.1% but buy volume hit 69% — indecision, not capitulation. A daily double bottom in the 1,700 area is taking shape and deserves close watch this week.

Reserved analysis Subscribe to read →
Reserved

AstraZeneca: powerful technical rebound, yet the sell signal holds

·45 min read
EXECUTIVE VIEW

AstraZeneca sell signal at week 8 with a 20% technical rebound from a double bottom testing bearish conviction. This week's strong recovery creates a key inflection, but flow indicators remain in a fragile balance worth monitoring.

Reserved analysis Subscribe to read →
Reserved

Allianz SE: +8% trade, coverage complete, residual capital running

·46 min read
EXECUTIVE VIEW

Allianz SE weekly technical analysis — week 11 of a buy setup, +8.1% performance, model coverage complete, residual capital running with trailing stop on the Inversion Point.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn